Doctor profile · Federal record
Dr. Anna Belcheva, M. D.
Medical Oncology Physician (CMS: Medical Oncology) · Hematology & Oncology Physician · Houston, TX
- NPI 1518928514
- Accepts Medicare
- 28 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
18220 State Highway 249, Suite 130
Houston, TX 770704347
(281) 737-0435
fax (281) 737-0429
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- November 16, 2017
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Texas #L2798
- Medicaid (5)
- TX #162526104 · TX #162526105 · TX #162526103 · TX #162526106 · TX #162526102
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1518928514. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
63,994
Distinct HCPCS
10
Medicare allowed
$783,918
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 23,460 | 29 | $1 | |
J1756 |
Injection, iron sucrose, 1 mg | 9,800 | 21 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 9,400 | 15 | $54 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 8,040 | 15 | $3 | |
J1453 |
Injection, fosaprepitant, 1 mg | 4,950 | 11 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 4,080 | 22 | $22 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,041 | 47 | $0 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 579 | 225 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 534 | 200 | $129 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 430 | 14 | $1 |
In context: peer comparison
Among 72 peers in Houston Medical Oncology Physician, average services per provider: 632. This provider delivers 101× the peer median.Open Payments
Industry payments received
All-time total
$4,017
Transactions
126
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 16 | $356.65 | |
| Janssen Biotech, INC. | 13 | $344.25 | |
| SpringWorks Therapeutics, INC. | 15 | $267.55 | |
| Novartis Pharmaceuticals Corporation | 13 | $255.14 | |
| Tempus Ai, INC | 12 | $224.11 | |
| Pfizer INC. | 11 | $205.55 | |
| Celgene Corporation | 6 | $156.42 | |
| Daiichi Sankyo INC. | 6 | $141.72 | |
| Eisai INC. | 6 | $132.91 | |
| Astellas Pharma US INC | 7 | $123.73 | |
| Sobi, INC | 4 | $109.82 | |
| Takeda Pharmaceuticals U.S.A., INC. | 5 | $106.05 | |
| Genzyme Corporation | 4 | $100.13 | |
| Jazz Pharmaceuticals INC. | 4 | $95.21 | |
| Gilead Sciences, INC. | 4 | $84.14 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
587
Patients
152
Total drug cost
$12,690
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 123 | 38 | $3,335 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 67 | 18 | $2,719 |
| Tramadol Hcl | Generic | 56 | 22 | $300 |
| Tamoxifen Citrate | Generic | 52 | 15 | $1,674 |
| Gabapentin | Generic | 42 | 15 | $385 |
| Ondansetron Odt (Ondansetron) | Brand | 39 | 21 | $435 |
| Dexamethasone | Generic | 34 | 12 | $331 |
| Alprazolam | Generic | 26 | 0 | $360 |
| Levothyroxine Sodium | Generic | 26 | 0 | $240 |
| Celecoxib | Generic | 22 | 0 | $2,160 |
Hospital affiliations
Frequently asked questions
What is Dr. Anna Belcheva's medical specialty?
Dr. Anna Belcheva practices Medical Oncology Physician in Houston, TX.
Where does Dr. Anna Belcheva practice?
Dr. Anna Belcheva practices at 18220 State Highway 249, Houston, TX 770704347. Office phone: 2817370435.
What is Dr. Anna Belcheva's NPI?
Dr. Anna Belcheva's National Provider Identifier (NPI) is 1518928514, issued by NPPES.
Does Dr. Anna Belcheva accept Medicare assignment?
Yes. Dr. Anna Belcheva accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Anna Belcheva commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, iron sucrose, 1 mg (HCPCS J1756); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.